Personalized Medicine: Advances in personalized medicine are paving the way for more tailored treatments
National Institutes of Health research shows that early diagnosis enables doctors to start antibiotic treatment, which results in mild symptom relief and major decreases in both medical complications and disease spread
For individuals with Hashimotos Thyroiditis struggling with weight management, the search for effective treatment options is paramount
Get to Know Erica Giamanco, Olympias Manager of Commercial Sales
On the other hand, with IBD-current biologic therapies limited to blocking tumor necrosis factor alpha some theoretical/practical inconsistencies appear
For individuals with severe immunodeficiency or functional/anatomical asplenia who received PPSV23 before age 65, a second PPSV23 dose is recommended at least 5 years after the first dose and at least 1 year after PCV15 administration, even if the individual is not yet 65 years old
